返回
Biocure Technology Inc (BICTF) 收益
BICTF 股价走势图
BICTF 收益
Biocure Technology Inc
$0.01
0%
$0
收盘价：Mar 24, 16:00:00 GMT-4
$0.01
0%
$0
盘前：Mar 25, 09:00:06 GMT-4
关键数据
前收盘价
$0.01
开盘价
$0.01
当日区间
$0.01 - $0.07
52周范围
$0.0012 - $0.63
交易量
1.0K
平均成交量
0
股息收益率
--
每股收益（TTM）
-0.02
市值
$154.4K
什么是 BIOCURE TECHNOLOGY INC？
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2008-03-27. The firm specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.
